No Prescription |
 |
 | ||
|
Seroflo Inhaler Advair Inhaler |
|
| ||
No Prescription » Prescription Drugs 14 » Seroflo Inhaler Advair Inhaler Fluticasone (floo-TIK-a-sone) and salmeterol (sal-ME-te-role) is a combination of two medicines that are used to help control the symptoms of asthma and improve lung function. Long-term prevention and treatment of asthma and chronic lung diseases. It should not be used to treat a sudden symptom of shortness of breath (eg sudden severe onset or worsening of wheezing cough chest tightness) because it does not work right away. It may also be used to treat other breathing conditions as determined by your doctor.Seretide Diskus is a combination "controller" medicine. It improves lung function and makes breathing easier by reducing airway swelling and irritation and by causing muscle relaxation. Fluticasone is a steroid. It prevents the release of substances in the body that cause inflammation. Salmeterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing.Fluticasone and salmeterol inhalation is used to prevent asthma attacks. Fluticasone and salmeterol inhalation is also used to treat chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis.Maintenance treatment of asthma where use of combination product is appropriate (eg patients inadequately controlled with inhaled corticosteroids or patients stabilised on salmeterol and fluticasone) Severe COPD with repeated exacerbations inadequately controlled with regular beta2 agonist therapy. Buy Seroflo Inhaler Advair Inhaler and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About Seroflo Inhaler Advair Inhaler: Product Type: Prescription Drugs 14 Seroflo Inhaler ( Advair Inhaler Generic Salmeterol/Fluticasone ) Seroflo Inhaler (Advair Inhaler Generic Salmeterol/Fluticasone) Advair Inhaler Generic Salmeterol/Fluticasone 25/125mcg 4 x 120 MD 25/125mcg 120 MD 25/125mcg 2 x 120 MD 25/250mcg 120 MD 25/250mcg 480 (4 x 120 MD) 25/250mcg 240 (2 x 120) MD 25/50mcg 2 x 120 MD 25/50mcg 120 MD 25/50mcg 4 x 120 MD Advair Inhaler Generic Salmeterol/Fluticasone Seroflo Inhaler
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
